LEMAITRE VASCULAR, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
LEMAITRE VASCULAR, INC. (LMAT) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-02-26
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-12-31 was -$64.00K, a 223.08% decline year-over-year.
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-09-30 was -$24.00K, a 123.30% decline year-over-year.
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-06-30 was -$23.00K.
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-03-31 was -$23.00K.
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was $0.00.
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was -$134.00K, a 216.52% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2023 was $115.00K, a 24.84% decline from fiscal 2022.
- LEMAITRE VASCULAR, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2022 was $153.00K, a 79.55% decline from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||||||
| 2024-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$88.00K derived: sum of 2 quarters · filed 2026-02-26 | -$111.00K derived: sum of 3 quarters · filed 2026-02-26 | -$134.00K 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$47.00K derived: sum of 2 quarters · filed 2024-11-08 | -$70.00K 10-Q · filed 2024-11-08 | -$18.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$46.00K 10-Q · filed 2024-08-08 | $6.00K derived: sum of 3 quarters · filed 2026-02-26 | $109.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$23.00K 10-Q · filed 2024-05-10 | $29.00K derived: sum of 2 quarters · filed 2026-02-26 | $132.00K derived: sum of 3 quarters · filed 2026-02-26 | $112.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $155.00K derived: sum of 2 quarters · filed 2026-02-26 | $135.00K derived: sum of 3 quarters · filed 2026-02-26 | $115.00K 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $83.00K derived: sum of 2 quarters · filed 2024-11-08 | $63.00K 10-Q · filed 2024-11-08 | $257.00K derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$40.00K 10-Q · filed 2024-08-08 | $154.00K derived: sum of 3 quarters · filed 2025-02-28 | $140.00K derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | -$20.00K 10-Q · filed 2024-05-10 | $174.00K derived: sum of 2 quarters · filed 2025-02-28 | $160.00K derived: sum of 3 quarters · filed 2025-02-28 | $147.00K derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $194.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $180.00K derived: sum of 2 quarters · filed 2025-02-28 | $167.00K derived: sum of 3 quarters · filed 2025-02-28 | $153.00K 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$27.00K derived: sum of 2 quarters · filed 2023-11-07 | -$41.00K 10-Q · filed 2023-11-07 | $199.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$27.00K 10-Q · filed 2023-08-08 | $213.00K derived: sum of 3 quarters · filed 2024-02-29 | $782.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$14.00K 10-Q · filed 2022-05-10 | $226.00K derived: sum of 2 quarters · filed 2024-02-29 | $795.00K derived: sum of 3 quarters · filed 2024-02-29 | $764.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $809.00K derived: sum of 2 quarters · filed 2024-02-29 | $778.00K derived: sum of 3 quarters · filed 2024-02-29 | $748.00K 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $569.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $538.00K derived: sum of 2 quarters · filed 2022-11-08 | $508.00K 10-Q · filed 2022-11-08 | $477.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$61.00K 10-Q · filed 2022-08-05 | -$92.00K derived: sum of 3 quarters · filed 2023-03-01 | -$74.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$30.00K 10-Q · filed 2022-05-10 | -$61.00K derived: sum of 2 quarters · filed 2023-03-01 | -$43.00K derived: sum of 3 quarters · filed 2023-03-01 | -$72.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$13.00K derived: sum of 2 quarters · filed 2023-03-01 | -$42.00K derived: sum of 3 quarters · filed 2023-03-01 | -$70.00K 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$11.00K derived: sum of 2 quarters · filed 2021-11-04 | -$39.00K 10-Q · filed 2021-11-04 | -$64.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$57.00K 10-Q · filed 2021-08-05 | -$82.00K derived: sum of 3 quarters · filed 2022-02-28 | -$82.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | -$28.00K 10-Q · filed 2021-05-10 | -$53.00K derived: sum of 2 quarters · filed 2022-02-28 | -$53.00K derived: sum of 3 quarters · filed 2022-02-28 | -$53.00K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$25.00K derived: sum of 2 quarters · filed 2022-02-28 | -$25.00K derived: sum of 3 quarters · filed 2022-02-28 | -$12.00K 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $13.00K 10-Q · filed 2020-11-06 | $18.00K derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.00K 10-Q · filed 2020-08-06 | $18.00K derived: sum of 3 quarters · filed 2021-03-12 | $84.00K derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $13.00K 10-Q · filed 2020-05-08 | -$13.00K 10-Q · filed 2019-05-06 | $18.00K derived: sum of 2 quarters · filed 2021-03-12 | $84.00K derived: sum of 3 quarters · filed 2021-03-12 | $12.00K derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2018-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $71.00K derived: sum of 2 quarters · filed 2021-03-12 | -$1.00K derived: sum of 3 quarters · filed 2021-03-12 | $29.00K 10-K · filed 2021-03-12 | -$29.00K 10-K · filed 2019-03-11 | |||
| 2018-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$6.00K derived: sum of 2 quarters · filed 2019-11-08 | $24.00K 10-Q · filed 2019-11-08 | -$24.00K 10-Q · filed 2018-11-02 | -$154.00K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | -$72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$42.00K 10-Q · filed 2019-08-06 | $42.00K 10-Q · filed 2018-08-06 | -$220.00K derived: sum of 3 quarters · filed 2020-03-12 | -$183.00K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | $30.00K 10-Q · filed 2019-05-06 | -$148.00K derived: sum of 2 quarters · filed 2020-03-12 | -$111.00K derived: sum of 3 quarters · filed 2020-03-12 | -$99.00K derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | -$178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$141.00K derived: sum of 2 quarters · filed 2020-03-12 | -$129.00K derived: sum of 3 quarters · filed 2020-03-12 | -$106.00K 10-K · filed 2020-03-12 | $106.00K 10-K · filed 2018-03-09 | |||
| 2017-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $49.00K derived: sum of 2 quarters · filed 2018-11-02 | $72.00K 10-Q · filed 2018-11-02 | |||||
| 2017-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $35.00K 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | $23.00K 10-Q · filed 2018-05-04 | |||||||
| 2016-12-31 | $87.00K 10-K · filed 2019-03-11 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $138.00K 10-K · filed 2017-03-09 | ||||||
| 2014-09-30 | $138.00K 10-Q · filed 2014-11-06 | |||||||
| 2013-12-31 | $57.00K 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |